This MedLibrary.org supplementary page on Methamphetamine Precursor Control Act is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
The Methamphetamine Precursor Control Act (MPCA), Senate Bill 273, is an Illinois state law that was signed into law on November 16, 2005, and took effect on January 15, 2006. The MPCA is an act used to create significant barriers such as the requirement to present ID to purchase cold medication that contains pseudoephedrine (Sudafed, Tylenol Cold and Claritin D) which could be used to produce methamphetamine. This is one of many state laws regulating the supply of pseudoephedrine that preceded the federal Combat Methamphetamine Epidemic Act of 2005.
|
|||||
 |
This Illinois-related article is a stub. You can help Wikipedia by expanding it. |
 |
This article relating to law in the United States is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 21 September 2008, at 13:31.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Methamphetamine Precursor Control Act".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.